P074 Significant efficacy and long term safety difference with taf-based str in naïve adults
Sign Up to like & getrecommendations! Published in 2017 at "Sexually Transmitted Infections"
DOI: 10.1136/sextrans-2017-053232.119
Abstract: Introduction At Week(W) 48, elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) was statistically noninferior to E/C/F/tenofovir disoproxil fumarate(TDF) for the proportion of subjects with HIV-1 RNA read more here.
Keywords: participants taf; p074 significant; renal safety; safety ... See more keywords